Johnson & Johnson reported 1.1 percent worldwide growth in the orthopedics segment for the first quarter of 2018, but believes the line will grow as the year goes on, according to the earnings call as posted in Seeking Alpha.
Author: Staff
India revealed plans to implement a price cap on medical devices last year and the U.S. plans to review import benefits as a result, according to The Wire.
In the first quarter of 2017, Johnson & Johnson reported their orthopedics business, DePuy Synthes, had a slight 1.1 percent growth over the same period last year.
The global CT scanner market is expected to surpass $7 billon by 2024, according to a market research report by Global Market Insights.
SpinalCyte is a Houston-based tissue engineering company developing a spinal nucleus replacement solution using human dermal fibroblasts.
Ceterix Orthopaedics' NovoStitch Pro Meniscal Repair System earned FDA 510(k) clearance.
Peter D. Angevine, MD, is a board-certified neurosurgeon at The Spine Hospital at New York City-based Columbia University's The Neurological Institute of New York.
The global spinal fusion devices market was worth nearly $7.5 billion in 2016, based on a Coherent Market Insights report, according to Healthcare News.
Vail, Colo.-based Steadman Philippon Research Institute is partnering with the United States Olympic Committee to present the 2nd Annual Injury Prevention Symposium.
Durham, N.C.-based Duke Health researchers assessed the impact of a one-page form given to patients prior to their appointments.
